18.57 USD
▼-0.48-2.52%
盘后 18.56 -0.05%
2026-09-15
市值
$1.62B
市盈率
—
EPS
-17.13
股息率
—
52 周区间
16.25 – 27.00
成交量
344.90K
Beta
—
目标价
42.25
52W 低 16.2552W 高 27.00
价格走势
公司简介
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI-based tools, real-world clinical data, and cardiac-specific analytics to optimize clinical study design, patient screening, and efficacy tracking. The...